Phathom Pharmaceuticals, Inc. — Form 8-K
Filed November 18, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Phathom Pharmaceuticals filed an 8-K on November 18, 2026 (covering event date November 12, 2026) reporting Item 5.02 disclosure regarding departure of directors or officers and/or appointment of officers with compensatory arrangement changes. The filing does not provide specific names, dollar amounts, equity grants, or detailed terms of any arrangements in the submitted text.
Why this rating
Bare 8-K header with no substantive details disclosed. Officer changes are routine; lack of specifics prevents assessment of materiality relative to $555.5M market cap.
Extracted items
See more from November 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.